Free Trial
→ They're not buying gold. They're buying this. (From Behind the Markets) (Ad)tc pixel
LON:GENI

GENinCode Final Earnings Report

GENinCode logo
GBX 0.68 -0.02 (-2.57%)
As of 11:59 AM Eastern
ProfileEarnings History

GENinCode EPS Results

Actual EPS
-GBX 2.53
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GENinCode Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GENinCode Announcement Details

Quarter
Final
Date
6/4/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

GENinCode Earnings Headlines

GENinCode (LON:GENI) Issues Earnings Results
September 30, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31069127
GENinCode Reports £1.1 Million H1 Revenue as Adjusted EBITDA Loss Narrows
September 29, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/genincode-reports-1-1-million-071328837.html
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.tc pixel
October 6 at 1:00 AM  |  Behind the Markets (Ad)
GENinCode Plc Reports Earnings Results for the Half Year Ended June 30, 2026
September 29, 2026  |  marketscreener.comM
GENinCode shares fall after revenue outlook cut and cash runway warning
September 29, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/genincode-shares-fall-revenue-outlook-083000894.html
GENinCode sets date for interim results as genetic risk platform gains strategic momentum
September 22, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/genincode-sets-date-for-interim-results-as-genetic-risk-platform-gains-strategic-momentum?utm_source=marketbeat.com&utm_medium=referral
See More GENinCode Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GENinCode? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GENinCode and other key companies, straight to your email.

About GENinCode

GENinCode (LON:GENI) is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.

View GENinCode Profile
Earnings Tools